COMMUNIQUÉS West-GlobeNewswire

Probiodrug Reports Management Changes
05/10/2018
Probiodrug Reports Management Changes HALLE (SAALE), Germany, October 5th, 2018 - Probiodrug AG ("Probiodrug", Euronext: PBD), a clinical stage biopharmaceutical company developing novel therapeutic solutions to treat [...]
ObsEva SA Announces Phase 3 IMPLANT 2 Clinical Trial Results of Nolasiban in IVF to be Presented at Annual ASRM Meeting Tuesday October 9, 2018
05/10/2018
Recipient of Prize Paper Award from the Society for Assisted Reproductive Technology (SART) Geneva, Switzerland and Boston, MA - October 5, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage [...]
Canada House Wellness Group Inc. Announces Closing of First Tranche under Alumina Facility
05/10/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc ("Canada House" or the "Company") (CSE: CHV) is pleased to [...]
MediciNova Announces FDA Grants Orphan Drug Designation to MN-166 (ibudilast) for Glioblastoma
05/10/2018
LA JOLLA, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]
Emergent BioSolutions Completes Acquisition of Specialty Vaccines Company PaxVax
05/10/2018
GAITHERSBURG, Md., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has completed its acquisition of PaxVax, a company focused on developing, manufacturing, and [...]
LeMaitre Vascular Announces Preliminary Q3 2018 Results
04/10/2018
BURLINGTON, Mass., Oct. 04, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, announced today Q3 2018 preliminary unaudited results, provided Q4 2018 [...]
Insmed Extends Patent Protection in Japan to 2033
04/10/2018
New Patent Adds 7 ½ Years of Market Exclusivity in Japan BRIDGEWATER, N.J., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients [...]
Study Demonstrating Globus Medical’s Expandable Technology Improves Lordosis and Reduces Subsidence Awarded Best Paper at SMISS
04/10/2018
AUDUBON, Pa., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, announced today that a recent clinical study evaluating static versus expandable lateral [...]
Corvus Pharmaceuticals to Present Data on Lead Programs at the European Society for Medical Oncology (ESMO) 2018 Congress and the Society for Immunotherapy of Cancer (SITC) Annual Meeting
04/10/2018
BURLINGAME, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
KemPharm Announces Proposed Public Offering of Common Stock
04/10/2018
CORALVILLE, Iowa, Oct. 04, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that it intends to [...]
Cutera Updates Full Year 2018 Revenue Guidance
04/10/2018
truSculpt ® iD Sets Company Record for New System Launch Earnings Call Scheduled for November 6 BRISBANE, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. ( CUTR ) (“Cutera” or the “Company”), a leading provider [...]
GBT Announces New Employment Inducement Grants
04/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that, on October 1, 2018, the compensation committee of the Company’s board of directors [...]
Akcea and Ionis Announce Approval of TEGSEDI™ (inotersen injection) in Canada
04/10/2018
First and only treatment of its kind for Canadians with Hereditary Transthyretin-mediated Amyloidosis (hATTR amyloidosis) with Polyneuropathy – a rare and inherited disease OTTAWA and BOSTON and CARLSBAD, Calif., Oct. [...]
Akcea and Ionis Announce Approval of TEGSEDI™ (inotersen injection) in Canada
04/10/2018
First and only treatment of its kind for Canadians with Hereditary Transthyretin-mediated Amyloidosis (hATTR amyloidosis) with Polyneuropathy – a rare and inherited disease OTTAWA and BOSTON and CARLSBAD, Calif., Oct. [...]
Akcea et Ionis annoncent l’homologation de TEGSEDIMC (inotersen pour injection) au Canada
04/10/2018
Le premier et le seul traitement de ce type pour les Canadiens atteints d’amylose héréditaire liée à la transthyrétine (hATTR) avec polyneuropathie, une maladie héréditaire rare OTTAWA et BOSTON et CARLSBAD, Californie [...]
Krystal Biotech to Present at Chardan Annual Genetic Medicines Conference
04/10/2018
PITTSBURGH, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin [...]
Allscripts and Appriss Health Partner to Provide Access to Prescription Drug Monitoring Program Information and the NarxCare Substance Use Disorder Platform
04/10/2018
Integration will enable Allscripts ePrescribe and EHR users to gain access to critical information and insights within clinical workflows; improves patient safety and outcomes through Appriss Health’s PMP Gateway [...]
Paratek Announces Acceptance of European Marketing Authorization Application for Oral and Intravenous Omadacycline
04/10/2018
-- MAA submission for both community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) -- -- EMA decision expected second half of 2019 -- BOSTON, Oct. 04, 2018 (GLOBE [...]
Histogenics Corporation Announces Proposed Public Offering of Common Stock and Warrants
04/10/2018
WALTHAM, Mass., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies, today announced that it intends to offer and sell shares [...]

Pages